Currently holds positions in TRACON Pharmaceuticals Inc and Evofem Biosciences Inc
Position | Company | Period |
---|---|---|
Director | TRACON Pharmaceuticals Inc | March 14, 2020 - |
President, Chief Executive Officer, Director | Evofem Biosciences Inc | Jan. 17, 2018 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-05-31 | 2022-05-27 |
Evofem Biosciences Inc
(EVFM)
|
B Purchase |
141,000
+147.3%
0.3549,703 USD |
141,000 +147.3% | 0.35 | 49,703 USD | |
2021-12-20 | 2021-12-20 |
Evofem Biosciences Inc
(EVFM)
|
B Purchase |
135,000
+15.9%
0.3850,625 USD |
135,000 +15.9% | 0.38 | 50,625 USD | |
2021-06-10 | 2021-06-10 |
Evofem Biosciences Inc
(EVFM)
|
B Purchase |
50,000
+6.2%
1.0351,500 USD |
50,000 +6.2% | 1.03 | 51,500 USD | |
2021-03-09 | 2021-03-09 |
Evofem Biosciences Inc
(EVFM)
|
PP Planned purchase |
45,249
+5.3%
2.28103,168 USD |
45,249 +5.3% | 2.28 | 103,168 USD | |
2020-09-10 | 2020-09-08 |
Evofem Biosciences Inc
(EVFM)
|
S Sale |
122,500
-25.3%
3.26399,350 USD |
122,500 -25.3% | 3.26 | 399,350 USD | |
2020-06-16 | 2020-06-15 |
TRACON Pharmaceuticals Inc
(TCON)
|
B Purchase |
3,000
+120.0%
2.076,209 USD |
3,000 +120.0% | 2.07 | 6,209 USD | |
2020-06-16 | 2020-06-11 |
TRACON Pharmaceuticals Inc
(TCON)
|
B Purchase |
2,500
+inf%
2.005,000 USD |
2,500 +inf% | 2.00 | 5,000 USD | |
2020-01-15 | 2020-01-13 |
Evofem Biosciences Inc
(EVFM)
|
PS Planned sale |
3,295
-0.9%
6.0019,770 USD |
3,295 -0.9% | 6.00 | 19,770 USD | |
2020-01-06 | 2020-01-02 |
Evofem Biosciences Inc
(EVFM)
|
PS Planned sale |
6,705
-1.8%
6.0540,565 USD |
6,705 -1.8% | 6.05 | 40,565 USD | |
2019-12-04 | 2019-12-02 |
Evofem Biosciences Inc
(EVFM)
|
PS Planned sale |
20,000
-5.1%
7.30146,000 USD |
20,000 -5.1% | 7.30 | 146,000 USD | |
2018-08-13 | 2018-08-10 |
Evofem Biosciences Inc
(EVFM)
|
B Purchase |
10,000
+3.0%
2.1121,100 USD |
10,000 +3.0% | 2.11 | 21,100 USD |